Page last updated: 2024-08-17

pentaerythritol tetranitrate and Diabetes Mellitus, Type 2

pentaerythritol tetranitrate has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giani, G; Haastert, B; Icks, A; Rathmann, W; Schröder-Bernhardi, D1

Other Studies

1 other study(ies) available for pentaerythritol tetranitrate and Diabetes Mellitus, Type 2

ArticleYear
Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany.
    International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:9

    Topics: Aged; Aged, 80 and over; Cost-Benefit Analysis; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Germany, East; Germany, West; Humans; Isosorbide Dinitrate; Male; Multivariate Analysis; Myocardial Ischemia; Pentaerythritol Tetranitrate; Practice Patterns, Physicians'; Primary Health Care; Regression Analysis; Vasodilator Agents

2007